Details for Patent: 12,544,337
Which drugs does patent 12,544,337 protect, and when does it expire?
Patent 12,544,337 protects ORLYNVAH and is included in one NDA.
This patent has sixteen patent family members in twelve countries.
Summary for Patent: 12,544,337
| Title: | Combinations of beta-lactam compounds and probenecid and uses thereof |
| Abstract: | The present disclosure relates to bilayer tablets comprising a second layer comprising a β-lactam compound or a pharmaceutically acceptable salt thereof; and a first layer comprising probenecid or a pharmaceutically acceptable salt thereof. The present disclosure also relates to methods of treating or preventing a disease using the bilayer tablets. |
| Inventor(s): | Michael Dunne, Tom LOUGHMAN, Aaron CAMERON |
| Assignee: | Iterum Therapeutics International Ltd |
| Application Number: | US17/948,790 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 12,544,337
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Iterum Therap | ORLYNVAH | probenecid; sulopenem etzadroxil | TABLET;ORAL | 213972-001 | Oct 25, 2024 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | USE IN TREATING UNCOMPLICATED URINARY TRACT INFECTIONS CAUSED BY ESCHERICHIA COLI, KLEBSIELLA PNEUMONIAE, OR PROTEUS MIRABILIS | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,544,337
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 117510 | ⤷ Start Trial | |||
| Australia | 2019429755 | ⤷ Start Trial | |||
| Brazil | 112021015744 | ⤷ Start Trial | |||
| Canada | 3129337 | ⤷ Start Trial | |||
| China | 112739330 | ⤷ Start Trial | |||
| China | 119770442 | ⤷ Start Trial | |||
| Eurasian Patent Organization | 202192193 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
